XCR1 and neoplasm: Furthermore, we observed that tumor development skewed the DC response towards DC1s that do not express CD103, which could be due to a decreased CD103 expression on XCR1+ cells; this phenomenon was previously described by us in response to LPS-induced lung inflammation [8].